Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Coronary atherosclerosis. A multifactorial disease

J J Badimon1, V Fuster, J H Chesebro

  • 1Cardiac Unit, Massachusetts General Hospital, Harvard Medical School, Boston 02114.

Circulation
|March 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HDL therapy today: from atherosclerosis, to stent compatibility to heart failure.

Annals of medicine·2019
Same author

LDL cholesterol-lowering therapies: emphasis on proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors.

Drugs of today (Barcelona, Spain : 1998)·2019
Same author

Dual versus triple antithrombotic therapy: is there a role for direct oral anticoagulants in arterial thrombosis?

Drugs of today (Barcelona, Spain : 1998)·2019
Same author

Incomplete reversibility of platelet inhibition following prolonged exposure to ticagrelor: comment.

Journal of thrombosis and haemostasis : JTH·2018
Same author

Niacin is still beneficial. Implications from an updated meta-regression analysis.

Acta cardiologica·2016
Same author

Muramidase: A useful monocyte/macrophage immunocytochemical marker in swine, of special interest in experimental cardiovascular disease.

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology·2015

Atherosclerosis develops through a multifactorial process involving vascular injury, lipid deposition, and cell proliferation. Thrombosis accelerates lesion progression and acute ischemic events, presenting therapeutic challenges.

Area of Science:

  • Cardiovascular Biology
  • Pathogenesis of Atherosclerosis

Background:

  • Atherosclerosis pathogenesis integrates multiple theories into a multifactorial model.
  • Early atherosclerosis involves vascular dysfunction, monocyte recruitment, lipid deposition, smooth muscle cell proliferation, and extracellular matrix synthesis.
  • The interplay of these factors shapes the atherosclerotic plaque.

Purpose of the Study:

  • To explore the multifactorial pathogenesis of atherosclerosis.
  • To identify key events in early and late atherogenesis.
  • To discuss therapeutic strategies for managing atherosclerosis and preventing acute coronary events.

Main Methods:

  • Review and integration of existing theories on atherosclerosis pathogenesis.
  • Analysis of experimental and clinical data on atherosclerotic progression.

Related Experiment Videos

  • Evaluation of therapeutic approaches targeting risk factors, lipid removal, and thrombosis.

    • Main Results:

    • Atherosclerosis progression involves vascular injury, inflammation, lipid accumulation, and smooth muscle cell proliferation.
    • Thrombus formation significantly accelerates lesion development and is critical in acute ischemic syndromes.
    • Experimental and clinical data support distinct pathways in atherosclerotic progression.

    Conclusions:

    • Therapeutic challenges include retarding or regressing atherosclerosis.
    • Strategies include managing risk factors (e.g., lipids), enhancing lipid removal (e.g., HDL levels), and antithrombotic therapy.
    • Targeting lipid-rich plaques and preventing thrombosis are key to preventing acute coronary events.